260 related articles for article (PubMed ID: 15025121)
41. Researcher said his colleague should have revealed possible conflicts of interest.
Maloney DM
Hum Res Rep; 2005 Jan; 20(1):8. PubMed ID: 15810184
[No Abstract] [Full Text] [Related]
42. Questionable experiments, muddled defence.
Kuhse H; Singer P
Bioethics; 1994 Oct; 8(4):iii-. PubMed ID: 11654120
[No Abstract] [Full Text] [Related]
43. Who is buying bioethics research?
Sharp RR; Scott AL; Landy DC; Kicklighter LA
Am J Bioeth; 2008 Aug; 8(8):54-8; discussion W1-2. PubMed ID: 18802867
[TBL] [Abstract][Full Text] [Related]
44. A public culture for guinea pigs: US human research subjects after the Tuskegee study.
Weinstein M
Sci Cult (Lond); 2001 Jun; 10(2):195-223. PubMed ID: 15971362
[No Abstract] [Full Text] [Related]
45. In that case. A multi-national pharmaceutical company wishes to recruit some of your patients to a pharmaco-genetic study. Response.
Holloway JW
N Z Bioeth J; 2002 Jun; 3(2):29-30. PubMed ID: 15587497
[No Abstract] [Full Text] [Related]
46. Governing population genomics: law, bioethics, and biopolitics in three case studies.
Winickoff DE
Jurimetrics; 2003; 43(2):187-228. PubMed ID: 15156881
[TBL] [Abstract][Full Text] [Related]
47. Regulation of research on the decisionally impaired: history and gaps in the current regulatory system.
Moreno JD
J Health Care Law Policy; 1998; 1(1):1-21. PubMed ID: 15573427
[No Abstract] [Full Text] [Related]
48. The benefits and threats of research partnerships with industry.
Duval G
Crit Care; 2005 Aug; 9(4):309-10. PubMed ID: 16137365
[No Abstract] [Full Text] [Related]
49. Sustainability and the balancing of the health care and innovation agendas: the commercialization of genetic research.
Caulfield T
Sask Law Rev; 2003; 66(2):629-45. PubMed ID: 15212021
[No Abstract] [Full Text] [Related]
50. Chinese villages and their sustainable future: the European Union-China-Research Project "SUCCESS".
Dumreicher H
J Environ Manage; 2008 Apr; 87(2):204-15. PubMed ID: 17888563
[TBL] [Abstract][Full Text] [Related]
51. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine.
Finkel AG
Headache; 2006; 46(7):1181-5. PubMed ID: 16866722
[No Abstract] [Full Text] [Related]
52. University uses "implied informed consent".
Maloney DM
Hum Res Rep; 2005 Mar; 20(3):6-7. PubMed ID: 15856566
[No Abstract] [Full Text] [Related]
53. Sociology. Scientific misconduct: do the punishments fit the crime?
Redman BK; Merz JF
Science; 2008 Aug; 321(5890):775. PubMed ID: 18687942
[No Abstract] [Full Text] [Related]
54. Bioethics. U.S. questions Harvard research in China.
Lawler A
Science; 2002 Apr; 296(5565):28. PubMed ID: 11934995
[No Abstract] [Full Text] [Related]
55. Cornell University scientists face charges of fraud.
Ready T
Nat Med; 2005 Aug; 11(8):810. PubMed ID: 16079859
[No Abstract] [Full Text] [Related]
56. Is academic medicine for sale?
Jagger J
N Engl J Med; 2000 Aug; 343(7):509; author reply 510. PubMed ID: 10950672
[No Abstract] [Full Text] [Related]
57. [Medical research and the pharmaceutical industry. Uneasy bedfellows or a prenuptial agreement?].
Cohen AF
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1438-42. PubMed ID: 11503309
[TBL] [Abstract][Full Text] [Related]
58. In that case. A multi-national pharmaceutical company wishes to recruit some of your patients to a pharmaco-genetic study. Response.
Wee R
N Z Bioeth J; 2002 Jun; 3(2):31-2. PubMed ID: 15587498
[No Abstract] [Full Text] [Related]
59. Divided loyalties: trust in science is being eroded. How can we restore it?
New Sci; 2005 Feb 26-Mar 4; 185(2488):3. PubMed ID: 15839009
[No Abstract] [Full Text] [Related]
60. Temporary insanity?
Barie PS
Surg Infect (Larchmt); 2005; 6(2):181-4. PubMed ID: 16128624
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
